The expression of p21 is upregulated by forkhead box A1/2 in p53-null H1299 cells

FEBS Letters

Volumn 588, Issue 21, 2014, Pages 4065-4070

  An, Joo Hee ^a   Jang, Sang Min ^a   Kim, Jung Woong ^a,b   Kim, Chul Hong ^a   Song, Peter I ^c   Choi, Kyung Hee ^a  

^a Chung Ang University   (South Korea)

^b NATIONAL EYE INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

p21; p53 Independent pathway; Target gene; Transcription factor FOXA1 2; Trichostatin A

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; PROTEIN P21; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FOXA1 PROTEIN, HUMAN; FOXA2 PROTEIN, HUMAN; HYDROXAMIC ACID; PROTEIN P53; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CARCINOMA CELL; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CARCINOMA; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; UPREGULATION; DEFICIENCY; DRUG EFFECTS; GENE DELETION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE DELETION; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; HYDROXAMIC ACIDS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84908180899     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.09.033     Document Type: Article

References (39)

1. J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816
2. W.S. el-Deiry WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
3. K.F. Macleod, N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks P53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage Genes Dev. 9 1995 935 944
4. Y.S. Jung, Y. Qian, and X. Chen Examination of the expanding pathways for the regulation of p21 expression and activity Cell. Signal. 22 2010 1003 1012
5. A.L. Gartel, E. Goufman, F. Najmabadi, and A.L. Tyner Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line Oncogene 19 2000 5182 5188
6. K. Somasundaram Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1 Nature 389 1997 187 190
7. R. Ju, and M.T. Muller Histone deacetylase inhibitors activate p21(WAF1) expression via ATM Cancer Res. 63 2003 2891 2897
8. H. Li, and X. Wu Histone deacetylase inhibitor, trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells Biochem. Biophys. Res. Commun. 324 2004 860 867
9. G. Narla, S. Kremer-Tal, N. Matsumoto, X. Zhao, S. Yao, K. Kelley, M. Tarocchi, and S.L. Friedman In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma Oncogene 26 2007 4428 4434
10. C.M. Aliouat-Denis P53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2 Mol. Cancer Res. 3 2005 627 634
11. E. Lai, K.L. Clark, S.K. Burley, and J.E. Darnell Jr. Hepatocyte nuclear factor 3/fork head or "winged helix" proteins: a family of transcription factors of diverse biologic function Proc. Natl. Acad. Sci. USA 90 1993 10421 10423
12. S.L. Ang, and J. Rossant HNF-3 beta is essential for node and notochord formation in mouse development Cell 78 1994 561 574
13. M.T. Stahlman, M.E. Gray, and J.A. Whitsett Temporal-spatial distribution of hepatocyte nuclear factor-3beta in developing human lung and other foregut derivatives J. Histochem. Cytochem. 46 1998 955 962
14. H. Wan, Y. Xu, M. Ikegami, M.T. Stahlman, K.H. Kaestner, S.L. Ang, and J.A. Whitsett Foxa2 is required for transition to air breathing at birth Proc. Natl. Acad. Sci. USA 101 2004 14449 14454
15. K. Ikeda, J.R. Shaw-White, S.E. Wert, and J.A. Whitsett Hepatocyte nuclear factor 3 activates transcription of thyroid transcription factor 1 in respiratory epithelial cells Mol. Cell. Biol. 16 1996 3626 3636
16. R.J. Bohinski, R. Di Lauro, and J.A. Whitsett The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis Mol. Cell. Biol. 14 1994 5671 5681
17. C.D. Bingle, B.P. Hackett, M. Moxley, W. Longmore, and J.D. Gitlin Role of hepatocyte nuclear factor-3 alpha and hepatocyte nuclear factor-3 beta in Clara cell secretory protein gene expression in the bronchiolar epithelium Biochem. J. 308 Pt 1 1995 197 202
18. B. Halmos A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer Cancer Res. 64 2004 4137 4147
19. D.S. Basseres Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing Lung Cancer 77 2012 31 37
20. Y. Tang, G. Shu, X. Yuan, N. Jing, and J. Song FOXA2 functions as a suppressor of tumor metastasis by inhibition of epithelial-to-mesenchymal transition in human lung cancers Cell Res. 21 2011 316 326
21. A.P. Monaghan, K.H. Kaestner, E. Grau, and G. Schutz Postimplantation expression patterns indicate a role for the mouse forkhead/HNF-3 alpha, beta and gamma genes in determination of the definitive endoderm, chordamesoderm and neuroectoderm Development 119 1993 567 578
22. V. Besnard, S.E. Wert, W.M. Hull, and J.A. Whitsett Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues Gene Expr. Patterns 5 2004 193 208
23. S.M. Jang, J.W. Kim, C.H. Kim, D. Kim, S. Rhee, and K.H. Choi P19(ras) represses proliferation of non-small cell lung cancer possibly through interaction with neuron-specific enolase (NSE) Cancer Lett. 289 2010 91 98
24. J.W. Kim, S.M. Jang, C.H. Kim, J.H. An, E.J. Kang, and K.H. Choi Neural retina leucine-zipper regulates the expression of Ppp2r5c, the regulatory subunit of protein phosphatase 2A, in photoreceptor development FEBS J. 277 2010 5051 5060
25. L.M. Hellman, and M.G. Fried Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions Nat. Protoc. 2 2007 1849 1861
26. P. Branch, M. Masson, G. Aquilina, M. Bignami, and P. Karran Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells Oncogene 19 2000 3138 3145
27. S.C. Righetti, P. Perego, E. Corna, M.A. Pierotti, and F. Zunino Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selection Cell Growth Differ. 10 1999 473 478
28. P. Giannakakou, G. Poy, Z. Zhan, T. Knutsen, M.V. Blagosklonny, and T. Fojo Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer Oncogene 19 2000 3078 3085
29. S.M. Ryou Functional cross-talk between p73beta and NF-kappaB mediated by p300 Biochem. Biophys. Res. Commun. 345 2006 623 630
30. M. Ocker, and R. Schneider-Stock Histone deacetylase inhibitors: signalling towards p21cip1/waf1 Int. J. Biochem. Cell Biol. 39 2007 1367 1374
31. N. Gao, J. LeLay, M.Z. Vatamaniuk, S. Rieck, J.R. Friedman, and K.H. Kaestner Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development Genes Dev. 22 2008 3435 3448
32. Y. Sowa, T. Orita, S. Hiranabe-Minamikawa, K. Nakano, T. Mizuno, H. Nomura, and T. Sakai Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites Ann. NY. Acad. Sci. 886 1999 195 199
33. K. Nakano Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line J. Biol. Chem. 272 1997 22199 22206
34. N.K. Mukhopadhyay, E. Weisberg, D. Gilchrist, R. Bueno, D.J. Sugarbaker, and M.T. Jaklitsch Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer Ann. Thorac. Surg. 81 2006 1034 1042
35. A. Miyanaga Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model Mol. Cancer Ther. 7 2008 1923 1930
36. Y. Sowa, T. Orita, S. Minamikawa, K. Nakano, T. Mizuno, H. Nomura, and T. Sakai Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites Biochem. Biophys. Res. Commun. 241 1997 142 150
37. R.H. Costa, V.V. Kalinichenko, and L. Lim Transcription factors in mouse lung development and function Am. J. Physiol. Lung Cell. Mol. Physiol. 280 2001 L823 L838
38. P. Minoo, L. Hu, Y. Xing, N.L. Zhu, H. Chen, M. Li, Z. Borok, and C. Li Physical and functional interactions between homeodomain NKX2.1 and winged helix/forkhead FOXA1 in lung epithelial cells Mol. Cell. Biol. 27 2007 2155 2165
39. E.L. Snyder Nk2-1 represses a latent gastric differentiation program in lung adenocarcinoma Mol. Cell 50 2013 185 199